- Home
- RIGL vs TRUE Comparison
RIGL vs TRUE Comparison
Compare RIGL & TRUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- TRUE
- Stock Information
- Founded
- RIGL 1996
- TRUE 2005
- Country
- RIGL United States
- TRUE United States
- Employees
- RIGL N/A
- TRUE N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- TRUE Computer Software: Programming Data Processing
- Sector
- RIGL Health Care
- TRUE Technology
- Exchange
- RIGL Nasdaq
- TRUE Nasdaq
- Market Cap
- RIGL 486.4M
- TRUE 329.0M
- IPO Year
- RIGL 2000
- TRUE 2014
- Fundamental
- Price
- RIGL $20.99
- TRUE $3.45
- Analyst Decision
- RIGL Buy
- TRUE Strong Buy
- Analyst Count
- RIGL 5
- TRUE 3
- Target Price
- RIGL $34.80
- TRUE $4.50
- AVG Volume (30 Days)
- RIGL 216.6K
- TRUE 173.0K
- Earning Date
- RIGL 03-04-2025
- TRUE 02-18-2025
- Dividend Yield
- RIGL N/A
- TRUE N/A
- EPS Growth
- RIGL N/A
- TRUE N/A
- EPS
- RIGL 0.22
- TRUE N/A
- Revenue
- RIGL $157,374,000.00
- TRUE $170,678,000.00
- Revenue This Year
- RIGL $51.34
- TRUE $13.62
- Revenue Next Year
- RIGL $15.75
- TRUE $20.01
- P/E Ratio
- RIGL $94.25
- TRUE N/A
- Revenue Growth
- RIGL 21.65
- TRUE 10.77
- 52 Week Low
- RIGL $7.48
- TRUE $2.56
- 52 Week High
- RIGL $29.82
- TRUE $4.62
- Technical
- Relative Strength Index (RSI)
- RIGL 55.77
- TRUE 37.89
- Support Level
- RIGL $20.98
- TRUE $3.56
- Resistance Level
- RIGL $23.01
- TRUE $3.83
- Average True Range (ATR)
- RIGL 1.40
- TRUE 0.13
- MACD
- RIGL 0.31
- TRUE 0.02
- Stochastic Oscillator
- RIGL 70.13
- TRUE 10.17
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. TrueCar enables users to obtain market-based pricing data on new and used cars, and to connect with its network of TrueCar Certified Dealers.